Medical and Pharmaceutical QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics LEX Diagnostics develops molecular diagnostics to improve patient care by delivering clinical insights Joseph MortonJune 6, 2025
AI and Autonomy Alibaba Group gets FDA nod for cancer detection tool The tool can effectively detect early-stage cancers in asymptomatic patients Joseph MortonApril 24, 2025
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025
Medical and Pharmaceutical Scholar Rock stock skyrockets on successful phase 3 trial results The SAPPHIRE study demonstrated statistically significant and clinically meaningful improvements Joseph MortonOctober 7, 2024
Health & Wellness Breath Diagnostics takes aim at lung cancer with One Breath Early detection is crucial in improving survival rates and the chances of successful treatment for lung cancer Joseph MortonAugust 26, 2024
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
Health and Safety FDA to reject medical device applications without cyberattack protection plans As many as 40 per cent of end-of-life devices have no protection at all against cyberattacks Joseph MortonMarch 31, 2023
Medical and Pharmaceutical Natera and RenaCARE aim for early detection of kidney disease Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine... Joseph MortonAugust 11, 2022
Business The Mugglehead technology roundup: glowing health edition Here are five companies looking to improve our collective health in different ways. Joseph MortonJune 17, 2022
Cannabis Inadequate testing for CBD contaminants raises industry concerns: Leafreport Many distributors are choosing not to test their products for microbes, pesticides and heavy metals Rowan DunneMay 26, 2022